Ritholtz Wealth Management’sJosh Brown believes the best opportunity in the market right now is in a pharmaceutical stock that’s trading at the same price it was at more than 10 years ago. What To Know: Tuesday on CNBC’s “Fast Money Halftime Report,” Brown made the case for buying Pfizer Inc (NYSE:PFE) stock at current levels. “This is very far away from what people are doing. This stock is on the 52-week low list. It’s actually at an 11-year low. We haven’t seen it trade at these prices since December of 2013,” Brown said. “There’s just no great near-term catalyst for this stock, and as a res…
